Clinical trials
Terminated Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 5 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| GlaxoSmithKline | 4 |
| Adaptimmune | 3 |
| CytomX Therapeutics | 3 |
| AbbVie | 2 |
| Cell Genesys | 2 |
| Clovis Oncology, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Radboud University Medical Center | 2 |
| University Medical Center Groningen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 50 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Neoplasms by Site | 5 |
| Head and Neck Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Neoplasms by Histologic Type | 4 |
| Recurrence | 4 |
| Adenocarcinoma | 3 |
| Carcinoma | 3 |
| Liposarcoma, Myxoid | 3 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.